XML 44 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 07, 2014
Sep. 08, 2013
Cash flows from operating activities:    
Net income $ 114,554 $ 98,322
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 20,024 17,480
Gains on sale/disposal of assets (1,381) (71)
Amortization of deferred financing costs 4,046 4,264
Provision for deferred income taxes 1,008 6,031
Non-cash compensation expense 11,897 14,866
Tax impact from equity-based compensation (10,899) (12,025)
Other (888) (1,283)
Changes in operating assets and liabilities (19,476) (23,009)
Net cash provided by operating activities 118,885 104,575
Cash flows from investing activities:    
Capital expenditures (30,983) (20,286)
Proceeds from sale of assets 5,802 3,184
Changes in restricted cash 51,861 (3,273)
Other (1,365) 1,539
Net cash provided by (used in) investing activities 25,315 (18,836)
Cash flows from financing activities:    
Repayments of long-term debt and capital lease obligations (12,152) (18,268)
Proceeds from exercise of stock options 3,094 5,804
Tax impact from equity-based compensation 10,899 12,025
Purchases of common stock (82,407) (76,892)
Tax payments for restricted stock upon vesting (7,889) (7,888)
Payments of common stock dividends and equivalents (39,208) (23,223)
Net cash used in financing activities (127,663) (108,442)
Effect of exchange rate changes on cash and cash equivalents 16 (31)
Change in cash and cash equivalents 16,553 (22,734)
Cash and cash equivalents, at beginning of period 14,383 [1] 54,813
Cash and cash equivalents, at end of period $ 30,936 $ 32,079
[1] The balance sheet at December 29, 2013 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.